Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 2.13% | 132.49 | 0.0% | $3025.78m | |
| BNGO | BioNano Genomics, Inc. | 23.74% | 8.60 | 0.0% | $1456.10m | |
| GILD | Gilead Sciences, Inc. | 1.64% | 63.42 | 1.0% | $662.01m | |
| AMGN | Amgen, Inc. | 1.75% | 245.89 | 1.3% | $595.98m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.24% | 157.03 | 2.0% | $543.98m | |
| CRSP | CRISPR Therapeutics AG | -1.10% | 207.73 | 0.6% | $533.93m | |
| NVAX | Novavax, Inc. | -0.84% | 128.89 | 92.9% | $491.09m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.34% | 516.13 | 2.7% | $479.74m | |
| ILMN | Illumina, Inc. | 2.36% | 379.81 | 3.5% | $367.05m | |
| BIIB | Biogen, Inc. | -1.02% | 277.43 | 1.7% | $360.20m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 0.18% | 226.52 | 1.9% | $345.04m | |
| BNTX | BioNTech SE | -2.41% | 103.30 | 0.0% | $330.03m | |
| SRPT | Sarepta Therapeutics, Inc. | 2.77% | 92.39 | 13.8% | $291.46m | |
| OCGN | Ocugen, Inc. | 3.90% | 2.27 | 0.0% | $281.27m | |
| EDIT | Editas Medicine, Inc. | 6.91% | 81.16 | 7.9% | $262.03m |
Company Profile
Seneca Biopharma, Inc. operates as a biopharmaceutical company, which engages in the research, development, and commercialization of central nervous system therapies based on human neuronal stem cells and small molecule compounds. Its pipeline includes NSI-189 small molecule program, NSI-566 stem cell therapy program, and novel & proprietary chemical entity screening platform. The company was founded by I. Richard Garr, Karl Y. Johe, and Merrill Solomon in 1996 and is headquartered in Germantown, MD.